evidencegaps
Primary study · included by 1 review

Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial.

Yin 2023 · Yin Jun, Yuan Jingnan, Li Yunjin, et al. · Nature medicine · 2023

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Yin 2023 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.